This series will focus on basic, translational and clinical research related to the field of tumor microenvironment and immunotherapy. All article types are welcome in this article collection. The series is guest edited by Professors Bo Zhu, Qian Chu, and Shengxiang Ren.
The deadline for submissions is 21 January 2023. Submissions can be made via the journal's editorial management system. For more information, visit the full collection page.
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Delong Liu, New York Medical College
Kongming Wu, Tongji Medical College
"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."
Your browser needs to have JavaScript enabled to view this timeline
Discover the range of academic oncology titles at Springer Nature here.
Citation Impact
8.593 - 2-year Impact Factor (2021)
5.914 - 5-year Impact Factor (2021)
1.386 - Source Normalized Impact per Paper (SNIP)
1.301 - SCImago Journal Rank (SJR)
Speed
6 days to first decision for all manuscripts (Median)
27 days to first decision for reviewed manuscripts only (Median)
Usage
399,525 Downloads (2021)
443 Altmetric mentions (2021)
03 February 2022